Stokes Capital Advisors, LLC

Position in PFE — Pfizer Inc

CIK 1734460 GREENWOOD, SC

Position in PFE

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$552,034

+$85,204 QoQ

Shares Held

22,925

+37.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,687

of 2,821 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,779	$11,729,226
2	JNJ	Johnson & Johnson	43,686	$11,094,933
3	ABBV	AbbVie Inc.	37,456	$9,425,427
4	GILD	Gilead Sciences, Inc.	35,370	$4,468,645
5	AMGN	Amgen Inc	3,061	$1,108,449
6	MRK	Merck & Co., Inc.	5,373	$690,430
7	PFE	Pfizer Inc This page	22,925	$552,034
8	NVO	Novo Nordisk A S	8,600	$412,284

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$552,034	22,925	+37.9%	Shares	Other	2026-07-22
2026-03-31	$466,830	16,625	+127.0%	Shares	Defined	2026-04-24
2024-09-30	$211,985	7,325	0.0%	Shares	Sole	2024-10-07
2024-06-30	$204,953	7,325	0.0%	Shares	Sole	2024-07-19
2024-03-31	$203,268	7,325	-88.7%	Shares	Sole	2024-04-16
2022-12-31	$3,316,970	64,734	+1.4%	Shares	Sole	2023-01-18
2022-09-30	$2,794,076	63,850	-31.3%	Shares	Sole	2022-10-12
2022-06-30	$4,875,518	92,991	-1.0%	Shares	Sole	2022-07-13
2022-03-31	$4,862,031	93,916	-2.9%	Shares	Sole	2022-05-10
2021-12-31	$5,714,091	96,767	-1.3%	Shares	Sole	2022-01-31
2021-09-30	$4,218,076	98,072	+0.6%	Shares	Sole	2021-10-20
2021-06-30	$3,819,470	97,535	+2.7%	Shares	Sole	2021-07-14
2021-03-31	$3,441,705	94,996	—	Shares	Sole	2021-04-19
No filing history on record for this holder in this stock.